Catalog Number

• CVGQ0970

Pack for each Kit

• 1 X 96 Test

Description of Product GSD NovaLisa® SARS-CoV-2 (COVID-19) quantitative IgG

GSD NovaLisa® SARS-CoV-2 (COVID-19) quantitative IgG Immunoassay for the quantitative and qualitative detection of specific IgG-class antibodies to the spike protein of SARS-CoV-2. It is intended to aid in the diagnosis of patients suspected of having COVID-19 disease or asymptomatic presentation of SARS-CoV-2, to monitor antibody levels during and after a COVID-19 infection, and to determine antibody levels before and after a COVID-19 vaccination.